

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.97906815 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.12578265 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.53200131 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 5.49698153 |
| 5 | regulation of vitamin metabolic process (GO:0030656) | 5.47066941 |
| 6 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.46489992 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.26066891 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.26066891 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.26066891 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.26066891 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.26066891 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.26066891 |
| 13 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 5.15826924 |
| 14 | response to peptidoglycan (GO:0032494) | 4.99855677 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 4.57224506 |
| 16 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.51957274 |
| 17 | natural killer cell mediated immunity (GO:0002228) | 4.51957274 |
| 18 | response to muramyl dipeptide (GO:0032495) | 4.51843299 |
| 19 | regulation of podosome assembly (GO:0071801) | 4.47437986 |
| 20 | T-helper 1 type immune response (GO:0042088) | 4.39468502 |
| 21 | negative regulation of interleukin-17 production (GO:0032700) | 4.38054638 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.28909677 |
| 23 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.17617598 |
| 24 | defense response to protozoan (GO:0042832) | 4.17400800 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.14433966 |
| 26 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.11290735 |
| 27 | regulation of immunoglobulin secretion (GO:0051023) | 4.09871560 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 4.06803130 |
| 29 | positive regulation of interleukin-12 production (GO:0032735) | 4.06357143 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 4.01695495 |
| 31 | cellular response to nicotine (GO:0071316) | 4.00743344 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.98460637 |
| 33 | neutrophil activation (GO:0042119) | 3.95170007 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.94874615 |
| 35 | granulocyte activation (GO:0036230) | 3.94406753 |
| 36 | positive regulation of heat generation (GO:0031652) | 3.90767547 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.89766097 |
| 38 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84775184 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.82071552 |
| 40 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.79006262 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78685944 |
| 42 | response to host immune response (GO:0052572) | 3.78685944 |
| 43 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.76662310 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76406672 |
| 45 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.74938488 |
| 46 | positive regulation of defense response to virus by host (GO:0002230) | 3.74672831 |
| 47 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.72145193 |
| 48 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.71934535 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.71662464 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.71259958 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.71259958 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68036218 |
| 53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.67400153 |
| 54 | response to type I interferon (GO:0034340) | 3.66632217 |
| 55 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.64686104 |
| 56 | neutrophil mediated immunity (GO:0002446) | 3.64505199 |
| 57 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.62649159 |
| 58 | respiratory burst (GO:0045730) | 3.60375662 |
| 59 | modulation by symbiont of host cellular process (GO:0044068) | 3.58174077 |
| 60 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.55447000 |
| 61 | response to protozoan (GO:0001562) | 3.55077287 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 3.54770610 |
| 63 | negative regulation of amino acid transport (GO:0051956) | 3.54351733 |
| 64 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.49107596 |
| 65 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.48689968 |
| 66 | regulation of interleukin-17 production (GO:0032660) | 3.46041943 |
| 67 | regulation of fever generation (GO:0031620) | 3.45522375 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44681076 |
| 69 | superoxide anion generation (GO:0042554) | 3.44288305 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 3.43685569 |
| 71 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.42431693 |
| 72 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.41183138 |
| 73 | cellular response to interferon-beta (GO:0035458) | 3.40503105 |
| 74 | negative regulation of growth of symbiont in host (GO:0044130) | 3.39852327 |
| 75 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.39852327 |
| 76 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.39852327 |
| 77 | regulation of growth of symbiont in host (GO:0044126) | 3.39852327 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.39764437 |
| 79 | leukocyte mediated cytotoxicity (GO:0001909) | 3.38535068 |
| 80 | regulation of T-helper cell differentiation (GO:0045622) | 3.38214396 |
| 81 | cellular response to virus (GO:0098586) | 3.37559960 |
| 82 | positive regulation of interleukin-17 production (GO:0032740) | 3.36745435 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.36718719 |
| 84 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.36478903 |
| 85 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.35689453 |
| 86 | positive regulation of interferon-beta production (GO:0032728) | 3.34310902 |
| 87 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.32113133 |
| 88 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32092314 |
| 89 | response to host (GO:0075136) | 3.32092314 |
| 90 | response to host defenses (GO:0052200) | 3.32092314 |
| 91 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.31567673 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29737266 |
| 93 | negative regulation of viral genome replication (GO:0045071) | 3.28473977 |
| 94 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.28190609 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 3.27758399 |
| 96 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.26083206 |
| 97 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.25671093 |
| 98 | positive regulation of acute inflammatory response (GO:0002675) | 3.25008501 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24944922 |
| 100 | microglial cell activation (GO:0001774) | 3.23562433 |
| 101 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.22083070 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21343194 |
| 103 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.20712870 |
| 104 | cytokine secretion (GO:0050663) | 3.19442229 |
| 105 | regulation of interleukin-12 production (GO:0032655) | 3.18527682 |
| 106 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.18445571 |
| 107 | response to interferon-alpha (GO:0035455) | 3.18204076 |
| 108 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.17449378 |
| 109 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16992258 |
| 110 | germinal center formation (GO:0002467) | 3.14951056 |
| 111 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12548336 |
| 112 | * cellular response to lipopolysaccharide (GO:0071222) | 3.12261552 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12072873 |
| 114 | response to interferon-beta (GO:0035456) | 3.11372552 |
| 115 | kynurenine metabolic process (GO:0070189) | 3.09093105 |
| 116 | regulation of RIG-I signaling pathway (GO:0039535) | 3.08047455 |
| 117 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.07877308 |
| 118 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.07379873 |
| 119 | positive regulation of type 2 immune response (GO:0002830) | 3.06003692 |
| 120 | negative regulation of lipid storage (GO:0010888) | 3.05881113 |
| 121 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.05151943 |
| 122 | monocyte chemotaxis (GO:0002548) | 3.04961696 |
| 123 | myeloid leukocyte mediated immunity (GO:0002444) | 3.04722287 |
| 124 | regulation of T-helper 1 type immune response (GO:0002825) | 3.04438786 |
| 125 | reactive oxygen species biosynthetic process (GO:1903409) | 3.04321659 |
| 126 | regulation of mononuclear cell migration (GO:0071675) | 3.03958857 |
| 127 | * cellular response to molecule of bacterial origin (GO:0071219) | 3.03071544 |
| 128 | tryptophan catabolic process (GO:0006569) | 3.02107382 |
| 129 | indole-containing compound catabolic process (GO:0042436) | 3.02107382 |
| 130 | indolalkylamine catabolic process (GO:0046218) | 3.02107382 |
| 131 | adhesion of symbiont to host cell (GO:0044650) | 3.01404483 |
| 132 | virion attachment to host cell (GO:0019062) | 3.01404483 |
| 133 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01384037 |
| 134 | regulation of chronic inflammatory response (GO:0002676) | 3.01250620 |
| 135 | regulation of memory T cell differentiation (GO:0043380) | 2.99531834 |
| 136 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.98961497 |
| 137 | regulation of chemokine biosynthetic process (GO:0045073) | 2.97522380 |
| 138 | detection of molecule of bacterial origin (GO:0032490) | 2.96792958 |
| 139 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.95684513 |
| 140 | activation of MAPKKK activity (GO:0000185) | 2.95250842 |
| 141 | B cell mediated immunity (GO:0019724) | 2.95242495 |
| 142 | dendritic cell differentiation (GO:0097028) | 2.94307093 |
| 143 | positive regulation of humoral immune response (GO:0002922) | 2.93003964 |
| 144 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.92636828 |
| 145 | positive regulation of interleukin-10 production (GO:0032733) | 2.92583730 |
| 146 | I-kappaB phosphorylation (GO:0007252) | 2.91681410 |
| 147 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.91635708 |
| 148 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90870615 |
| 149 | positive regulation of interleukin-6 production (GO:0032755) | 2.89908191 |
| 150 | regulation of heat generation (GO:0031650) | 2.89868617 |
| 151 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.89733478 |
| 152 | positive regulation of B cell mediated immunity (GO:0002714) | 2.89733478 |
| 153 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88940079 |
| 154 | interferon-gamma secretion (GO:0072643) | 2.86494403 |
| 155 | response to ATP (GO:0033198) | 2.85646865 |
| 156 | regulation of type 2 immune response (GO:0002828) | 2.85156698 |
| 157 | cellular response to ATP (GO:0071318) | 2.85136902 |
| 158 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.85026365 |
| 159 | lymphocyte chemotaxis (GO:0048247) | 2.84699189 |
| 160 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.83281957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.21981915 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.13461547 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.03108535 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.48025290 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.44061571 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.38502633 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.25822462 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.09551545 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58499997 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43361526 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34121128 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27379486 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.12446804 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91475805 |
| 15 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88749237 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67213668 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55615411 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41175349 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25412477 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18729587 |
| 21 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.07511856 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06578158 |
| 23 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.96074961 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95363013 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93094638 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78895917 |
| 27 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.76929838 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73622930 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70767213 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70402800 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69299511 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69174865 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60614392 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58993653 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57415400 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53253668 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52179050 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52166076 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51911200 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.49527764 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48608744 |
| 42 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47087111 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43232630 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41814475 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39753097 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35743152 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35274962 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33569152 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31377358 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.27255210 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27054852 |
| 52 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25629238 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24764801 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23912638 |
| 55 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23267693 |
| 56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21356423 |
| 57 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20539879 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.20206562 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17935223 |
| 60 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17094075 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16896923 |
| 62 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15580970 |
| 63 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11670094 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11048915 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09322391 |
| 66 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09001633 |
| 67 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08054120 |
| 68 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08054120 |
| 69 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08054120 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05228781 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04159679 |
| 72 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99609519 |
| 73 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96430279 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96023089 |
| 75 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90460540 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90322621 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90235390 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89411811 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88690985 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88121914 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87842156 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87513445 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87513445 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85232814 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85148184 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83079670 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82746760 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82726918 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80731267 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80731267 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80029023 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79537714 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78175303 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77195893 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76324397 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75180407 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75101174 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74292329 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 0.74285140 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71855260 |
| 101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71374850 |
| 102 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.70983130 |
| 103 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67449432 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.66678123 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65239022 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.65133156 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64793366 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.64098200 |
| 109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.63166151 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62843398 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.62830443 |
| 112 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.62549063 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62185484 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61781322 |
| 115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.61114147 |
| 116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.60694960 |
| 117 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.60588238 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.60495814 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59979513 |
| 120 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.59938669 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59685423 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.59026678 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.58719508 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.58422393 |
| 125 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.57820361 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.57349503 |
| 127 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57215427 |
| 128 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.56876554 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.56512944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.95000435 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.54785819 |
| 3 | MP0009785_altered_susceptibility_to | 4.11030163 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.68457811 |
| 5 | MP0003436_decreased_susceptibility_to | 3.60040400 |
| 6 | MP0004510_myositis | 3.24473644 |
| 7 | MP0000685_abnormal_immune_system | 3.21842119 |
| 8 | MP0002419_abnormal_innate_immunity | 3.16143868 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.15149808 |
| 10 | MP0005025_abnormal_response_to | 3.07298519 |
| 11 | MP0005387_immune_system_phenotype | 2.86172384 |
| 12 | MP0001790_abnormal_immune_system | 2.86172384 |
| 13 | MP0005671_abnormal_response_to | 2.84871019 |
| 14 | MP0006082_CNS_inflammation | 2.78830045 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.71324591 |
| 16 | MP0001800_abnormal_humoral_immune | 2.64321113 |
| 17 | MP0002723_abnormal_immune_serum | 2.62388379 |
| 18 | MP0003724_increased_susceptibility_to | 2.52865461 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.40656621 |
| 20 | MP0003303_peritoneal_inflammation | 2.38040776 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.33573156 |
| 22 | MP0009278_abnormal_bone_marrow | 2.26988309 |
| 23 | MP0001819_abnormal_immune_cell | 2.26312619 |
| 24 | MP0005174_abnormal_tail_pigmentation | 2.23295613 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.21587706 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.13282042 |
| 27 | MP0004947_skin_inflammation | 2.11951752 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.10022426 |
| 29 | MP0003195_calcinosis | 2.09233356 |
| 30 | MP0008004_abnormal_stomach_pH | 2.04929640 |
| 31 | MP0002006_tumorigenesis | 2.03653709 |
| 32 | MP0009764_decreased_sensitivity_to | 1.96230047 |
| 33 | MP0001853_heart_inflammation | 1.78667975 |
| 34 | MP0003448_altered_tumor_morphology | 1.77380831 |
| 35 | MP0002405_respiratory_system_inflammati | 1.76784219 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.75263784 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.74843972 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.73877217 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.71335901 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.71335901 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.68251956 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.67754009 |
| 43 | MP0006054_spinal_hemorrhage | 1.62295913 |
| 44 | MP0005451_abnormal_body_composition | 1.61770371 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.60930907 |
| 46 | MP0008469_abnormal_protein_level | 1.58969413 |
| 47 | MP0000716_abnormal_immune_system | 1.58159286 |
| 48 | MP0005310_abnormal_salivary_gland | 1.51666408 |
| 49 | MP0002398_abnormal_bone_marrow | 1.51327777 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.47277941 |
| 51 | MP0003646_muscle_fatigue | 1.41483281 |
| 52 | MP0003075_altered_response_to | 1.40401011 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.40036677 |
| 54 | MP0000858_altered_metastatic_potential | 1.35047263 |
| 55 | MP0000343_altered_response_to | 1.33581539 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.27281898 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.22614477 |
| 58 | MP0002429_abnormal_blood_cell | 1.21663441 |
| 59 | MP0000371_diluted_coat_color | 1.16745178 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.15545527 |
| 61 | MP0008260_abnormal_autophagy | 1.13990336 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.10530294 |
| 63 | MP0002254_reproductive_system_inflammat | 1.09582777 |
| 64 | MP0009763_increased_sensitivity_to | 1.09033027 |
| 65 | MP0002722_abnormal_immune_system | 1.08150215 |
| 66 | MP0000604_amyloidosis | 1.07115108 |
| 67 | MP0005166_decreased_susceptibility_to | 1.06823668 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.05430809 |
| 69 | MP0001663_abnormal_digestive_system | 1.03757194 |
| 70 | MP0001542_abnormal_bone_strength | 0.94464522 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.93806305 |
| 72 | MP0010307_abnormal_tumor_latency | 0.92134148 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.90975514 |
| 74 | MP0005165_increased_susceptibility_to | 0.87514970 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.87509266 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.85901634 |
| 77 | MP0003763_abnormal_thymus_physiology | 0.83503260 |
| 78 | MP0003091_abnormal_cell_migration | 0.83417206 |
| 79 | MP0003690_abnormal_glial_cell | 0.81643515 |
| 80 | MP0005164_abnormal_response_to | 0.80324080 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.80236745 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.79295403 |
| 83 | MP0004381_abnormal_hair_follicle | 0.78744027 |
| 84 | MP0003828_pulmonary_edema | 0.77757008 |
| 85 | MP0005535_abnormal_body_temperature | 0.77522096 |
| 86 | MP0005390_skeleton_phenotype | 0.76852641 |
| 87 | MP0001851_eye_inflammation | 0.76666009 |
| 88 | MP0005647_abnormal_sex_gland | 0.76235442 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.75449540 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.74948895 |
| 91 | MP0009840_abnormal_foam_cell | 0.73745696 |
| 92 | MP0003866_abnormal_defecation | 0.71836268 |
| 93 | MP0001873_stomach_inflammation | 0.71748534 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.71642002 |
| 95 | MP0001958_emphysema | 0.70484700 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.70132714 |
| 97 | MP0005266_abnormal_metabolism | 0.70124191 |
| 98 | MP0002653_abnormal_ependyma_morphology | 0.68011041 |
| 99 | MP0002933_joint_inflammation | 0.67055976 |
| 100 | MP0001764_abnormal_homeostasis | 0.66967179 |
| 101 | MP0000490_abnormal_crypts_of | 0.66709361 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.65845157 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 0.65619629 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.64468318 |
| 105 | MP0000249_abnormal_blood_vessel | 0.64433007 |
| 106 | MP0008874_decreased_physiological_sensi | 0.64223319 |
| 107 | MP0002396_abnormal_hematopoietic_system | 0.61423803 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.61247216 |
| 109 | MP0002693_abnormal_pancreas_physiology | 0.61058272 |
| 110 | MP0005408_hypopigmentation | 0.60953002 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.59868327 |
| 112 | MP0002163_abnormal_gland_morphology | 0.59495473 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.59481289 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.58513858 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.57767354 |
| 116 | MP0000920_abnormal_myelination | 0.56604236 |
| 117 | MP0001919_abnormal_reproductive_system | 0.56490923 |
| 118 | MP0005171_absent_coat_pigmentation | 0.55032819 |
| 119 | MP0001346_abnormal_lacrimal_gland | 0.54633856 |
| 120 | MP0004043_abnormal_pH_regulation | 0.54025210 |
| 121 | MP0003045_fibrosis | 0.53695441 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.53605121 |
| 123 | MP0005023_abnormal_wound_healing | 0.53142369 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.52614219 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.51131658 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.51045196 |
| 127 | MP0000627_abnormal_mammary_gland | 0.50288464 |
| 128 | MP0005410_abnormal_fertilization | 0.48856235 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.47997042 |
| 130 | MP0005448_abnormal_energy_balance | 0.46511917 |
| 131 | MP0005319_abnormal_enzyme/_coenzyme | 0.45944189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.69467569 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.49026591 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.40529677 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.85304870 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.47130288 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.27334641 |
| 7 | Stomatitis (HP:0010280) | 5.21200385 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.87762509 |
| 9 | Prostate neoplasm (HP:0100787) | 4.77769527 |
| 10 | Recurrent skin infections (HP:0001581) | 4.63367837 |
| 11 | Optic neuritis (HP:0100653) | 4.48861531 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.48861531 |
| 13 | Myositis (HP:0100614) | 4.43090185 |
| 14 | Gingivitis (HP:0000230) | 4.34762020 |
| 15 | Orchitis (HP:0100796) | 4.28748790 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 4.15509490 |
| 17 | Vasculitis (HP:0002633) | 4.09958880 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.01315965 |
| 19 | Loss of speech (HP:0002371) | 3.95535569 |
| 20 | Increased IgM level (HP:0003496) | 3.93895548 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.89337089 |
| 22 | Periodontitis (HP:0000704) | 3.79277815 |
| 23 | Thick nail (HP:0001805) | 3.71981973 |
| 24 | Mutism (HP:0002300) | 3.65556028 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.46430245 |
| 26 | Obstructive lung disease (HP:0006536) | 3.44454894 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44454894 |
| 28 | Recurrent viral infections (HP:0004429) | 3.36520212 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30233351 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30233351 |
| 31 | T lymphocytopenia (HP:0005403) | 3.27254398 |
| 32 | Nuclear cataract (HP:0100018) | 3.21280771 |
| 33 | Parakeratosis (HP:0001036) | 3.20561481 |
| 34 | Pustule (HP:0200039) | 3.16954460 |
| 35 | Basal ganglia calcification (HP:0002135) | 3.11338793 |
| 36 | Leukocytosis (HP:0001974) | 2.99263907 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.98068055 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.96305010 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.96305010 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.96305010 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.93621622 |
| 42 | Urticaria (HP:0001025) | 2.92103028 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.89220365 |
| 44 | Premature loss of primary teeth (HP:0006323) | 2.88341739 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85746854 |
| 46 | Increased serum ferritin (HP:0003281) | 2.84445653 |
| 47 | Cellulitis (HP:0100658) | 2.79652737 |
| 48 | Amyloidosis (HP:0011034) | 2.79261360 |
| 49 | Nausea (HP:0002018) | 2.78473913 |
| 50 | Encephalitis (HP:0002383) | 2.77650073 |
| 51 | Axonal loss (HP:0003447) | 2.75186490 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.72949303 |
| 53 | Gingival bleeding (HP:0000225) | 2.71339935 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69094628 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.69094628 |
| 56 | Meningitis (HP:0001287) | 2.67997119 |
| 57 | Hemoptysis (HP:0002105) | 2.66789308 |
| 58 | Arterial thrombosis (HP:0004420) | 2.63667015 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.61658140 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.57646004 |
| 61 | Abnormality of the pleura (HP:0002103) | 2.56905540 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.55110163 |
| 63 | Osteomyelitis (HP:0002754) | 2.54904794 |
| 64 | Metaphyseal irregularity (HP:0003025) | 2.53916771 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.52886712 |
| 66 | B lymphocytopenia (HP:0010976) | 2.51050908 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.50482942 |
| 68 | Keratitis (HP:0000491) | 2.47086164 |
| 69 | Tetraparesis (HP:0002273) | 2.43756317 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.42069738 |
| 71 | Inappropriate behavior (HP:0000719) | 2.41263731 |
| 72 | Eosinophilia (HP:0001880) | 2.39658292 |
| 73 | Hematochezia (HP:0002573) | 2.36474683 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34428533 |
| 75 | Mesangial abnormality (HP:0001966) | 2.31739026 |
| 76 | Apathy (HP:0000741) | 2.29322853 |
| 77 | Abnormality of the pericardium (HP:0001697) | 2.28861695 |
| 78 | Vertigo (HP:0002321) | 2.27011961 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.25609223 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.25245850 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.24566495 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.24503017 |
| 83 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24450341 |
| 84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24450341 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24450341 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.22994672 |
| 87 | Fused cervical vertebrae (HP:0002949) | 2.22969476 |
| 88 | Disinhibition (HP:0000734) | 2.22700364 |
| 89 | Combined immunodeficiency (HP:0005387) | 2.21632430 |
| 90 | Diminished motivation (HP:0000745) | 2.20263809 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 2.20133612 |
| 92 | Agnosia (HP:0010524) | 2.19367138 |
| 93 | Pulmonary artery stenosis (HP:0004415) | 2.18580752 |
| 94 | Gangrene (HP:0100758) | 2.17864929 |
| 95 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.16638253 |
| 96 | IgA deficiency (HP:0002720) | 2.14002892 |
| 97 | Chronic otitis media (HP:0000389) | 2.12700227 |
| 98 | Bone pain (HP:0002653) | 2.11805317 |
| 99 | Anorexia (HP:0002039) | 2.10716765 |
| 100 | Episodic fever (HP:0001954) | 2.10518983 |
| 101 | Memory impairment (HP:0002354) | 2.10459938 |
| 102 | Pulmonary embolism (HP:0002204) | 2.07127838 |
| 103 | Abnormality of T cell number (HP:0011839) | 2.04775567 |
| 104 | Granulocytopenia (HP:0001913) | 2.04688080 |
| 105 | Acne (HP:0001061) | 2.04331511 |
| 106 | Arthralgia (HP:0002829) | 2.03158469 |
| 107 | Albinism (HP:0001022) | 2.01471408 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99786374 |
| 109 | Colitis (HP:0002583) | 1.99236955 |
| 110 | Epistaxis (HP:0000421) | 1.98389870 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97917122 |
| 112 | Porencephaly (HP:0002132) | 1.97563643 |
| 113 | Poor head control (HP:0002421) | 1.96876441 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.96209874 |
| 115 | IgG deficiency (HP:0004315) | 1.94174139 |
| 116 | Generalized aminoaciduria (HP:0002909) | 1.94068102 |
| 117 | Severe combined immunodeficiency (HP:0004430) | 1.94012629 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93610186 |
| 119 | Complement deficiency (HP:0004431) | 1.92257370 |
| 120 | Amaurosis fugax (HP:0100576) | 1.92251393 |
| 121 | Abnormality of eosinophils (HP:0001879) | 1.88984455 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 1.88552998 |
| 123 | Leukopenia (HP:0001882) | 1.87735267 |
| 124 | Glomerulopathy (HP:0100820) | 1.86568855 |
| 125 | Purpura (HP:0000979) | 1.86566766 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.86053034 |
| 127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86053034 |
| 128 | Joint swelling (HP:0001386) | 1.85472682 |
| 129 | Vertebral compression fractures (HP:0002953) | 1.85472069 |
| 130 | Joint hemorrhage (HP:0005261) | 1.85326164 |
| 131 | Glomerulonephritis (HP:0000099) | 1.84368835 |
| 132 | Absent frontal sinuses (HP:0002688) | 1.83915298 |
| 133 | Pathologic fracture (HP:0002756) | 1.83728238 |
| 134 | Thyroiditis (HP:0100646) | 1.83578182 |
| 135 | Submucous cleft hard palate (HP:0000176) | 1.83101655 |
| 136 | Prolonged bleeding time (HP:0003010) | 1.83040840 |
| 137 | Skin ulcer (HP:0200042) | 1.82568836 |
| 138 | Chest pain (HP:0100749) | 1.82495639 |
| 139 | Flat occiput (HP:0005469) | 1.82187068 |
| 140 | Cheilitis (HP:0100825) | 1.81323938 |
| 141 | Neoplasm of head and neck (HP:0012288) | 1.80803181 |
| 142 | Esophageal neoplasm (HP:0100751) | 1.80803181 |
| 143 | Myocardial infarction (HP:0001658) | 1.80745041 |
| 144 | Inflammation of the large intestine (HP:0002037) | 1.78872848 |
| 145 | Hepatosplenomegaly (HP:0001433) | 1.77900415 |
| 146 | Restrictive lung disease (HP:0002091) | 1.76818648 |
| 147 | Abnormality of the endocardium (HP:0004306) | 1.76068223 |
| 148 | Polyneuropathy (HP:0001271) | 1.75113499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.53404625 |
| 2 | RIPK4 | 4.54234829 |
| 3 | IRAK4 | 3.78890168 |
| 4 | TBK1 | 3.78604687 |
| 5 | IRAK3 | 3.55038801 |
| 6 | TAOK2 | 3.46346079 |
| 7 | IKBKE | 3.30609037 |
| 8 | DDR2 | 3.04425220 |
| 9 | TYK2 | 3.02482326 |
| 10 | IKBKB | 2.99484293 |
| 11 | MAP3K13 | 2.90951949 |
| 12 | BLK | 2.75996359 |
| 13 | JAK3 | 2.55513464 |
| 14 | TXK | 2.51308773 |
| 15 | KIT | 2.47355872 |
| 16 | TAOK1 | 2.36946592 |
| 17 | MAP3K11 | 2.27201075 |
| 18 | MAP4K1 | 2.14001274 |
| 19 | JAK1 | 2.04075843 |
| 20 | CHUK | 1.97699326 |
| 21 | TAOK3 | 1.97281441 |
| 22 | PBK | 1.94505907 |
| 23 | PIM2 | 1.85598516 |
| 24 | RIPK1 | 1.84771784 |
| 25 | MAP3K3 | 1.81692416 |
| 26 | SYK | 1.45529027 |
| 27 | EIF2AK2 | 1.45415674 |
| 28 | RPS6KA4 | 1.36285461 |
| 29 | TYRO3 | 1.35896694 |
| 30 | CSF1R | 1.35467986 |
| 31 | HCK | 1.34072921 |
| 32 | NEK9 | 1.33858333 |
| 33 | MAP2K6 | 1.33210732 |
| 34 | ACVR1B | 1.26969660 |
| 35 | ZAP70 | 1.25607376 |
| 36 | CDC42BPA | 1.24455511 |
| 37 | PIM1 | 1.18590247 |
| 38 | BMPR2 | 1.17996196 |
| 39 | BTK | 1.16404406 |
| 40 | CSK | 1.12186135 |
| 41 | LCK | 1.11254746 |
| 42 | YES1 | 1.10349017 |
| 43 | LYN | 1.09965636 |
| 44 | TEC | 1.04945673 |
| 45 | SIK2 | 1.02540940 |
| 46 | NME2 | 1.02140071 |
| 47 | FES | 0.99321295 |
| 48 | PRPF4B | 0.97525358 |
| 49 | MST1R | 0.94051113 |
| 50 | FGR | 0.94049802 |
| 51 | MST4 | 0.92988645 |
| 52 | JAK2 | 0.92303650 |
| 53 | STK4 | 0.91753267 |
| 54 | TRPM7 | 0.85188719 |
| 55 | MAP3K1 | 0.80907376 |
| 56 | EPHA3 | 0.78033535 |
| 57 | DYRK3 | 0.76605864 |
| 58 | SIK3 | 0.75375368 |
| 59 | MARK3 | 0.74416617 |
| 60 | BMX | 0.73103333 |
| 61 | ERBB3 | 0.72315107 |
| 62 | EPHB1 | 0.71532659 |
| 63 | ARAF | 0.68002610 |
| 64 | LATS2 | 0.66665838 |
| 65 | STK10 | 0.66646834 |
| 66 | ADRBK2 | 0.66472534 |
| 67 | ABL1 | 0.65069861 |
| 68 | TLK1 | 0.65049510 |
| 69 | TTN | 0.64792155 |
| 70 | DAPK2 | 0.63465147 |
| 71 | PRKCD | 0.63179837 |
| 72 | TGFBR2 | 0.61858375 |
| 73 | EGFR | 0.61450128 |
| 74 | FGFR3 | 0.61414395 |
| 75 | ABL2 | 0.60564557 |
| 76 | MATK | 0.56074643 |
| 77 | CAMKK2 | 0.54764164 |
| 78 | MAP3K5 | 0.51486887 |
| 79 | GRK7 | 0.51188690 |
| 80 | MUSK | 0.50107326 |
| 81 | MAP2K3 | 0.48681190 |
| 82 | CDK6 | 0.47301117 |
| 83 | PTK6 | 0.46789658 |
| 84 | DAPK3 | 0.46745866 |
| 85 | HIPK2 | 0.46044094 |
| 86 | ERN1 | 0.45682797 |
| 87 | FLT3 | 0.44547178 |
| 88 | CDK12 | 0.43061571 |
| 89 | PRKCQ | 0.42185969 |
| 90 | STK3 | 0.38709012 |
| 91 | IRAK1 | 0.38087003 |
| 92 | MAPK4 | 0.37709682 |
| 93 | IRAK2 | 0.37600440 |
| 94 | MAPKAPK2 | 0.37384821 |
| 95 | NUAK1 | 0.36400352 |
| 96 | RPS6KA5 | 0.35815821 |
| 97 | INSR | 0.35640900 |
| 98 | NLK | 0.34503036 |
| 99 | CAMK1D | 0.33906349 |
| 100 | PKN1 | 0.32556135 |
| 101 | CLK1 | 0.31147358 |
| 102 | FYN | 0.30464990 |
| 103 | RPS6KA6 | 0.30409703 |
| 104 | PDK1 | 0.30253882 |
| 105 | MOS | 0.29788320 |
| 106 | SGK1 | 0.29248260 |
| 107 | PRKCE | 0.27806200 |
| 108 | PDPK1 | 0.27543874 |
| 109 | PDGFRB | 0.26925872 |
| 110 | GSK3A | 0.24727285 |
| 111 | PLK2 | 0.24483048 |
| 112 | BMPR1B | 0.24047256 |
| 113 | ITK | 0.23041875 |
| 114 | IGF1R | 0.21386075 |
| 115 | CAMK1G | 0.20528690 |
| 116 | ATR | 0.19584597 |
| 117 | DAPK1 | 0.19144241 |
| 118 | PDGFRA | 0.18893023 |
| 119 | FGFR4 | 0.15595818 |
| 120 | ERBB4 | 0.15266789 |
| 121 | PIK3CA | 0.14300635 |
| 122 | RPS6KA2 | 0.14052846 |
| 123 | SRC | 0.13139619 |
| 124 | CSNK1A1 | 0.13125918 |
| 125 | RPS6KL1 | 0.10187437 |
| 126 | RPS6KC1 | 0.10187437 |
| 127 | GRK5 | 0.08069686 |
| 128 | PRKAA2 | 0.08051530 |
| 129 | CSNK1G3 | 0.07904728 |
| 130 | FRK | 0.07878312 |
| 131 | GRK1 | 0.07154132 |
| 132 | CSNK1A1L | 0.06464584 |
| 133 | MAPK3 | 0.05594261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.62088373 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.47386194 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17855890 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.98480756 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.94200902 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.83290421 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.78093416 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.53314471 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.50200282 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.40479739 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.37889236 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.29535833 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29196054 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.27113302 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.23908059 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16322851 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.13110754 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.07076708 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 2.05413767 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05296389 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.03751324 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96897863 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.92950013 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62605729 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62424135 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57854985 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55483281 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54610725 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.52809343 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.49336593 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43715741 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40928146 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.39736836 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38011018 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35542493 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29408504 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.24410068 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.20685330 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19994260 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.17177580 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10052660 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09371315 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08954967 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.04848590 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02593581 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89013103 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88798270 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88660402 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.86686910 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86223585 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80245485 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76383223 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71943032 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71253966 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68991539 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64469321 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.64192333 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64095420 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63964645 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63207625 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62250363 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61893125 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59553602 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59225665 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57879018 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57867613 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.53238620 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52680202 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52284220 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52263195 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51849150 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51518273 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46313587 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43764670 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43109129 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40208994 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.39292527 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37720341 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37244745 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37193495 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33638770 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33555215 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30106561 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29936470 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29859191 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28793639 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27843612 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27497304 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27477329 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24271423 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23815327 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.23157269 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22865376 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22664322 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21718791 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20778646 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20481534 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18360539 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16258489 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.15899611 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.15600175 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.15565560 |
| 103 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15341604 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15339837 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15252982 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14098130 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13735721 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13724278 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12717127 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11191208 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10952006 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10866289 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.09411183 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.09012058 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08073930 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07874995 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03667713 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0143911 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0045788 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0037762 |

